In MDS/MPN overlap syndrome, Sanada et al. also discovered a CBL gain-of-function mutation can contribute to loss of the ubiquitin E3 ligase activity, thereby prohibiting ubiquitin-mediated degradation of tyrosine kinases, resulting in constitutive activation of tyrosine kinase signaling. This evidence concerns the gene CBL and myelodysplastic syndrome.